Closing the medication safety gap across Africa with AI that verifies authenticity, speaks local languages, and works offline.
40 million smartphone users targeted in Phase 1
In Sub-Saharan Africa, the simple act of taking medication carries unacceptable risk.
This is not a supply problem. It is a trust and guidance problem. RxAssist exists to solve it at population scale.
A 24/7 digital pharmacist that combines computer vision for counterfeit detection with intelligent, multilingual clinical support — designed from the ground up for low-connectivity environments.
High-resolution smartphone scanning analyzes holograms, serial numbers, and packaging security features against a proprietary manufacturer database. Instant Trust Score in seconds.
Clinical guidance delivered in Yoruba, Hausa, Igbo, Pidgin, and English. Complex dosage instructions and side-effect warnings become clear in the patient’s mother tongue.
Sync-and-Save architecture. Core databases and adherence schedules remain fully functional even when cellular data is unavailable — critical for rural communities.
AI-driven reminders, drug-drug and drug-food interaction alerts, and intelligent nudges to complete antibiotic courses — protecting both the individual and public health from resistance.
A deliberate, phased approach to building sustainable pharmaceutical infrastructure across the continent.
Launch in Lagos urban hubs and select rural clusters in Northern Nigeria. Focus on 40 million smartphone users. Deep NLP training for major local languages.
Scale to Ghana and Côte d’Ivoire. Adapt NLP models for additional dialects. Strengthen B2B partnerships with regional pharmacy chains and health systems.
Pan-African rollout. Capture meaningful share of the $65 billion African pharmaceutical market. Become the default layer of medication safety infrastructure.
Founder & Visionary
The Nigeria pilot launches in late 2026. Early access is limited to patients, healthcare professionals, and partners who want to shape the future of medication safety in Africa.
Thank you. We’ll notify you the moment pilot access opens in Nigeria. Your voice will help shape a safer future for medication across Africa.